

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.39380540 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.97834530 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 6.97834530 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.81216036 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.95581064 |
| 6 | electron transport chain (GO:0022900) | 5.81443274 |
| 7 | protein neddylation (GO:0045116) | 5.63706286 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 5.37598259 |
| 9 | protein complex biogenesis (GO:0070271) | 4.87854344 |
| 10 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.85285588 |
| 11 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.85285588 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 4.85285588 |
| 13 | proteasome assembly (GO:0043248) | 4.59637146 |
| 14 | negative regulation of telomere maintenance (GO:0032205) | 4.41850797 |
| 15 | axon ensheathment in central nervous system (GO:0032291) | 4.37264710 |
| 16 | central nervous system myelination (GO:0022010) | 4.37264710 |
| 17 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.33215238 |
| 18 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.19006510 |
| 19 | ribosomal small subunit biogenesis (GO:0042274) | 4.14272363 |
| 20 | DNA damage response, detection of DNA damage (GO:0042769) | 4.00726448 |
| 21 | GTP biosynthetic process (GO:0006183) | 3.88596934 |
| 22 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.87802358 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.84995262 |
| 24 | respiratory chain complex IV assembly (GO:0008535) | 3.83285439 |
| 25 | fatty acid elongation (GO:0030497) | 3.78232347 |
| 26 | hydrogen ion transmembrane transport (GO:1902600) | 3.75153556 |
| 27 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.73973909 |
| 28 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.73973909 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.73589262 |
| 30 | cotranslational protein targeting to membrane (GO:0006613) | 3.72591664 |
| 31 | termination of RNA polymerase III transcription (GO:0006386) | 3.70235713 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.70235713 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 3.67516934 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.65835228 |
| 35 | cytochrome complex assembly (GO:0017004) | 3.64746198 |
| 36 | viral transcription (GO:0019083) | 3.60997283 |
| 37 | protein targeting to ER (GO:0045047) | 3.60768503 |
| 38 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.59900012 |
| 39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.57835528 |
| 40 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.57101083 |
| 41 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.55738593 |
| 42 | 7-methylguanosine mRNA capping (GO:0006370) | 3.55730382 |
| 43 | protein localization to endoplasmic reticulum (GO:0070972) | 3.54139339 |
| 44 | sequestering of actin monomers (GO:0042989) | 3.54043134 |
| 45 | protein targeting to mitochondrion (GO:0006626) | 3.53445539 |
| 46 | ribosomal large subunit biogenesis (GO:0042273) | 3.52890285 |
| 47 | regulation of helicase activity (GO:0051095) | 3.51694383 |
| 48 | 7-methylguanosine RNA capping (GO:0009452) | 3.51240996 |
| 49 | RNA capping (GO:0036260) | 3.51240996 |
| 50 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.49270532 |
| 51 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.49270532 |
| 52 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.48682639 |
| 53 | negative regulation of ligase activity (GO:0051352) | 3.48460000 |
| 54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.48460000 |
| 55 | proton transport (GO:0015992) | 3.46843209 |
| 56 | translational termination (GO:0006415) | 3.46329542 |
| 57 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.45627075 |
| 58 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.45627075 |
| 59 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.45627075 |
| 60 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.45168096 |
| 61 | protein-cofactor linkage (GO:0018065) | 3.43699593 |
| 62 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.43501032 |
| 63 | establishment of protein localization to mitochondrion (GO:0072655) | 3.43302976 |
| 64 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.42547542 |
| 65 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.42453351 |
| 66 | mannosylation (GO:0097502) | 3.40953494 |
| 67 | hydrogen transport (GO:0006818) | 3.38082464 |
| 68 | ATP biosynthetic process (GO:0006754) | 3.37278555 |
| 69 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.31915903 |
| 70 | intracellular protein transmembrane import (GO:0044743) | 3.30470226 |
| 71 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.29904827 |
| 72 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.29904827 |
| 73 | signal peptide processing (GO:0006465) | 3.28814087 |
| 74 | GPI anchor biosynthetic process (GO:0006506) | 3.28122004 |
| 75 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.26791049 |
| 76 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.26557108 |
| 77 | platelet dense granule organization (GO:0060155) | 3.25430377 |
| 78 | regulation of mitochondrial translation (GO:0070129) | 3.24269301 |
| 79 | protein localization to mitochondrion (GO:0070585) | 3.18674314 |
| 80 | negative regulation of telomerase activity (GO:0051974) | 3.15101676 |
| 81 | regulation of cellular amine metabolic process (GO:0033238) | 3.15006380 |
| 82 | cellular component biogenesis (GO:0044085) | 3.13058917 |
| 83 | translation (GO:0006412) | 3.12780965 |
| 84 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.11623448 |
| 85 | cullin deneddylation (GO:0010388) | 3.11131123 |
| 86 | UTP biosynthetic process (GO:0006228) | 3.10273180 |
| 87 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.09383901 |
| 88 | oxidative phosphorylation (GO:0006119) | 3.09192982 |
| 89 | translational initiation (GO:0006413) | 3.07564589 |
| 90 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.05662579 |
| 91 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.05570567 |
| 92 | pseudouridine synthesis (GO:0001522) | 3.05365439 |
| 93 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.03508436 |
| 94 | establishment of viral latency (GO:0019043) | 3.02910282 |
| 95 | rRNA modification (GO:0000154) | 2.99912975 |
| 96 | inner mitochondrial membrane organization (GO:0007007) | 2.97900144 |
| 97 | dopamine transport (GO:0015872) | 2.95610512 |
| 98 | protein deneddylation (GO:0000338) | 2.94489117 |
| 99 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.93083421 |
| 100 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.91652116 |
| 101 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.91481874 |
| 102 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.91481874 |
| 103 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.90847960 |
| 104 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.90437680 |
| 105 | establishment of integrated proviral latency (GO:0075713) | 2.90074829 |
| 106 | viral life cycle (GO:0019058) | 2.89844127 |
| 107 | substantia nigra development (GO:0021762) | 2.89828568 |
| 108 | translational elongation (GO:0006414) | 2.87911400 |
| 109 | maturation of 5.8S rRNA (GO:0000460) | 2.86584923 |
| 110 | aerobic respiration (GO:0009060) | 2.82020516 |
| 111 | CTP metabolic process (GO:0046036) | 2.81910235 |
| 112 | CTP biosynthetic process (GO:0006241) | 2.81910235 |
| 113 | GPI anchor metabolic process (GO:0006505) | 2.80583827 |
| 114 | DNA deamination (GO:0045006) | 2.80468098 |
| 115 | cellular protein complex disassembly (GO:0043624) | 2.79588274 |
| 116 | neutrophil activation involved in immune response (GO:0002283) | 2.79105293 |
| 117 | behavioral response to nicotine (GO:0035095) | 2.79045924 |
| 118 | peptidyl-histidine modification (GO:0018202) | 2.78508253 |
| 119 | mitochondrial transport (GO:0006839) | 2.78163681 |
| 120 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.77482640 |
| 121 | maturation of SSU-rRNA (GO:0030490) | 2.76681663 |
| 122 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.74851800 |
| 123 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.74654584 |
| 124 | positive regulation of ligase activity (GO:0051351) | 2.73691612 |
| 125 | nucleotide transmembrane transport (GO:1901679) | 2.72546755 |
| 126 | tRNA processing (GO:0008033) | 2.67828782 |
| 127 | protein targeting to membrane (GO:0006612) | 2.65126241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.10411815 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.63762255 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.49679066 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.13368783 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.97959786 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.92814705 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.89364834 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.69032109 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.21982970 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.11698507 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.07330384 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.06290066 |
| 13 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.64450668 |
| 14 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.61196690 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.54120122 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.53837649 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.32363496 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.29271146 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 2.19418351 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.10794951 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07240490 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97034538 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.91438322 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.91055190 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.89587024 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88241379 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.86597264 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86274254 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84404812 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79789922 |
| 31 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78045907 |
| 32 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.74106965 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72603226 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70406090 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64614189 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63967953 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57582049 |
| 38 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.57335163 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56156844 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54633319 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47530874 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.47098064 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45068178 |
| 44 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.43002104 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42731742 |
| 46 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.41123492 |
| 47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38842757 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34285764 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.34099773 |
| 50 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.33211284 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31989689 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.28611264 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27268531 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26920299 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25681891 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24291504 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23253640 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18318592 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.18200014 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14783742 |
| 61 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09229858 |
| 62 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08749152 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08412964 |
| 64 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08353618 |
| 65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07993752 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07657096 |
| 67 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06304924 |
| 68 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.04309333 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02529406 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01101427 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00460847 |
| 72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.00058225 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99116733 |
| 74 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98495839 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98224460 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98084445 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97960541 |
| 78 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97564166 |
| 79 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97564166 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97309409 |
| 81 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97210074 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96380756 |
| 83 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96032344 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95070136 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94663218 |
| 86 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93172781 |
| 87 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92272894 |
| 88 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90966885 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90311954 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90237671 |
| 91 | EWS_26573619_Chip-Seq_HEK293_Human | 0.89716314 |
| 92 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.88379039 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87525640 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86615715 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86295802 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.85314581 |
| 97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.84611043 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.84588341 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84112843 |
| 100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82795745 |
| 101 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82710437 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82124883 |
| 103 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.80388681 |
| 104 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.80127475 |
| 105 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.80005624 |
| 106 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79527232 |
| 107 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.79389494 |
| 108 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.79147995 |
| 109 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.78999052 |
| 110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78373441 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.78014609 |
| 112 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.77891959 |
| 113 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77708547 |
| 114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.76365515 |
| 115 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.75831722 |
| 116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75634050 |
| 117 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74798384 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74273406 |
| 119 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.73787013 |
| 120 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.73787013 |
| 121 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.73539709 |
| 122 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.73100040 |
| 123 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.71148257 |
| 124 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.69151755 |
| 125 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.68762017 |
| 126 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.68037585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001529_abnormal_vocalization | 3.75684602 |
| 2 | MP0003880_abnormal_central_pattern | 3.68714749 |
| 3 | MP0001905_abnormal_dopamine_level | 3.47402168 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.29637167 |
| 5 | MP0006072_abnormal_retinal_apoptosis | 2.55831106 |
| 6 | MP0001986_abnormal_taste_sensitivity | 2.37364792 |
| 7 | MP0000920_abnormal_myelination | 2.35993278 |
| 8 | MP0003136_yellow_coat_color | 2.34334808 |
| 9 | MP0004133_heterotaxia | 2.31480621 |
| 10 | MP0005171_absent_coat_pigmentation | 2.23907822 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.18831908 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.17420174 |
| 13 | MP0003011_delayed_dark_adaptation | 2.17228410 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.10562300 |
| 15 | MP0003724_increased_susceptibility_to | 2.06805426 |
| 16 | MP0006276_abnormal_autonomic_nervous | 2.02095227 |
| 17 | MP0003186_abnormal_redox_activity | 2.00582978 |
| 18 | MP0004142_abnormal_muscle_tone | 1.99354496 |
| 19 | MP0009785_altered_susceptibility_to | 1.96493243 |
| 20 | MP0002736_abnormal_nociception_after | 1.95216352 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 1.94886528 |
| 22 | MP0002163_abnormal_gland_morphology | 1.91419046 |
| 23 | MP0002638_abnormal_pupillary_reflex | 1.84229521 |
| 24 | MP0002272_abnormal_nervous_system | 1.78821896 |
| 25 | MP0008058_abnormal_DNA_repair | 1.77731011 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77429743 |
| 27 | MP0004742_abnormal_vestibular_system | 1.74934376 |
| 28 | MP0001188_hyperpigmentation | 1.73539417 |
| 29 | MP0005671_abnormal_response_to | 1.71722136 |
| 30 | MP0004147_increased_porphyrin_level | 1.68173910 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.67055113 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.66202942 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.65843925 |
| 34 | MP0008260_abnormal_autophagy | 1.64787728 |
| 35 | MP0008995_early_reproductive_senescence | 1.63574982 |
| 36 | MP0005253_abnormal_eye_physiology | 1.63361392 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.62878062 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.61208037 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.60774393 |
| 40 | MP0009046_muscle_twitch | 1.57309414 |
| 41 | MP0000631_abnormal_neuroendocrine_gland | 1.56127736 |
| 42 | MP0002064_seizures | 1.55106436 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.51882268 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.45056855 |
| 45 | MP0009745_abnormal_behavioral_response | 1.44259892 |
| 46 | MP0003121_genomic_imprinting | 1.39179072 |
| 47 | MP0003646_muscle_fatigue | 1.38912197 |
| 48 | MP0005408_hypopigmentation | 1.38907718 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.38739127 |
| 50 | MP0005409_darkened_coat_color | 1.38280109 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.37426776 |
| 52 | MP0001984_abnormal_olfaction | 1.36636920 |
| 53 | MP0001970_abnormal_pain_threshold | 1.35513014 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.35190975 |
| 55 | MP0006082_CNS_inflammation | 1.35149429 |
| 56 | MP0005423_abnormal_somatic_nervous | 1.33297225 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.32099123 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.32089673 |
| 59 | MP0004270_analgesia | 1.31864010 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.31441204 |
| 61 | MP0005025_abnormal_response_to | 1.27360615 |
| 62 | MP0003122_maternal_imprinting | 1.21728664 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.20695734 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.20613698 |
| 65 | MP0001727_abnormal_embryo_implantation | 1.18418059 |
| 66 | MP0004381_abnormal_hair_follicle | 1.18025602 |
| 67 | MP0001764_abnormal_homeostasis | 1.17698510 |
| 68 | MP0001486_abnormal_startle_reflex | 1.17311524 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.16888865 |
| 70 | MP0002234_abnormal_pharynx_morphology | 1.16476995 |
| 71 | MP0002938_white_spotting | 1.16141835 |
| 72 | MP0002572_abnormal_emotion/affect_behav | 1.13481948 |
| 73 | MP0002419_abnormal_innate_immunity | 1.13175657 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.13033606 |
| 75 | MP0008872_abnormal_physiological_respon | 1.12569956 |
| 76 | MP0005410_abnormal_fertilization | 1.11683798 |
| 77 | MP0002557_abnormal_social/conspecific_i | 1.11073848 |
| 78 | MP0001542_abnormal_bone_strength | 1.10981620 |
| 79 | MP0003786_premature_aging | 1.09781083 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 1.09398437 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.09260237 |
| 82 | MP0000015_abnormal_ear_pigmentation | 1.09174087 |
| 83 | MP0002067_abnormal_sensory_capabilities | 1.08484946 |
| 84 | MP0005195_abnormal_posterior_eye | 1.07737212 |
| 85 | MP0002733_abnormal_thermal_nociception | 1.06975386 |
| 86 | MP0003718_maternal_effect | 1.06474033 |
| 87 | MP0005394_taste/olfaction_phenotype | 1.05858340 |
| 88 | MP0005499_abnormal_olfactory_system | 1.05858340 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 1.05829586 |
| 90 | MP0003890_abnormal_embryonic-extraembry | 1.05797303 |
| 91 | MP0003137_abnormal_impulse_conducting | 1.03682270 |
| 92 | MP0006292_abnormal_olfactory_placode | 1.02324142 |
| 93 | MP0001853_heart_inflammation | 1.00129340 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.99726190 |
| 95 | MP0004924_abnormal_behavior | 0.99726190 |
| 96 | MP0002229_neurodegeneration | 0.97636288 |
| 97 | MP0002160_abnormal_reproductive_system | 0.97536446 |
| 98 | MP0002723_abnormal_immune_serum | 0.97389425 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.97321124 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.97025303 |
| 101 | MP0000647_abnormal_sebaceous_gland | 0.96283685 |
| 102 | MP0005332_abnormal_amino_acid | 0.95481213 |
| 103 | MP0003329_amyloid_beta_deposits | 0.92896659 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.91823525 |
| 105 | MP0001790_abnormal_immune_system | 0.91398715 |
| 106 | MP0005387_immune_system_phenotype | 0.91398715 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.90597145 |
| 108 | MP0003787_abnormal_imprinting | 0.90536374 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.90046955 |
| 110 | MP0005389_reproductive_system_phenotype | 0.89941060 |
| 111 | MP0002090_abnormal_vision | 0.89893862 |
| 112 | MP0008789_abnormal_olfactory_epithelium | 0.88538573 |
| 113 | MP0003634_abnormal_glial_cell | 0.87888511 |
| 114 | MP0001293_anophthalmia | 0.87760458 |
| 115 | MP0003690_abnormal_glial_cell | 0.87500636 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.86161772 |
| 117 | MP0002420_abnormal_adaptive_immunity | 0.85902126 |
| 118 | MP0002210_abnormal_sex_determination | 0.85539010 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.84765531 |
| 120 | MP0003635_abnormal_synaptic_transmissio | 0.84736623 |
| 121 | MP0001819_abnormal_immune_cell | 0.84597573 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.83541814 |
| 123 | MP0004215_abnormal_myocardial_fiber | 0.81295982 |
| 124 | MP0002452_abnormal_antigen_presenting | 0.80318603 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.79976693 |
| 126 | MP0003195_calcinosis | 0.78650611 |
| 127 | MP0005164_abnormal_response_to | 0.77978273 |
| 128 | MP0002928_abnormal_bile_duct | 0.76144156 |
| 129 | MP0002822_catalepsy | 0.75545470 |
| 130 | MP0009697_abnormal_copulation | 0.75081456 |
| 131 | MP0008932_abnormal_embryonic_tissue | 0.74794217 |
| 132 | MP0001919_abnormal_reproductive_system | 0.74204375 |
| 133 | MP0001324_abnormal_eye_pigmentation | 0.73908415 |
| 134 | MP0000026_abnormal_inner_ear | 0.73604331 |
| 135 | MP0005645_abnormal_hypothalamus_physiol | 0.73505619 |
| 136 | MP0002102_abnormal_ear_morphology | 0.73492603 |
| 137 | MP0000778_abnormal_nervous_system | 0.72888060 |
| 138 | MP0000049_abnormal_middle_ear | 0.72464330 |
| 139 | MP0005391_vision/eye_phenotype | 0.71765589 |
| 140 | MP0002751_abnormal_autonomic_nervous | 0.71507011 |
| 141 | MP0002184_abnormal_innervation | 0.71320820 |
| 142 | MP0002295_abnormal_pulmonary_circulatio | 0.71285845 |
| 143 | MP0003938_abnormal_ear_development | 0.71209904 |
| 144 | MP0002063_abnormal_learning/memory/cond | 0.70430085 |
| 145 | MP0004043_abnormal_pH_regulation | 0.70206309 |
| 146 | MP0002332_abnormal_exercise_endurance | 0.70168063 |
| 147 | MP0002132_abnormal_respiratory_system | 0.69858890 |
| 148 | MP0001929_abnormal_gametogenesis | 0.68256847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.53378644 |
| 2 | Mitochondrial inheritance (HP:0001427) | 5.90138434 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.83578722 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.44588217 |
| 5 | Acute encephalopathy (HP:0006846) | 5.20572370 |
| 6 | Increased hepatocellular lipid droplets (HP:0006565) | 5.01380956 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.95016156 |
| 8 | Increased CSF lactate (HP:0002490) | 4.94022604 |
| 9 | Renal Fanconi syndrome (HP:0001994) | 4.70245687 |
| 10 | 3-Methylglutaconic aciduria (HP:0003535) | 4.49416453 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 4.37962005 |
| 12 | Hepatic necrosis (HP:0002605) | 4.27494828 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.13205794 |
| 14 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 4.06441244 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 3.69550913 |
| 16 | Exertional dyspnea (HP:0002875) | 3.68236400 |
| 17 | Parakeratosis (HP:0001036) | 3.64447118 |
| 18 | Increased serum pyruvate (HP:0003542) | 3.62169538 |
| 19 | Abnormality of glycolysis (HP:0004366) | 3.62169538 |
| 20 | Leukodystrophy (HP:0002415) | 3.59791344 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.56441420 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.56441420 |
| 23 | Exercise intolerance (HP:0003546) | 3.47004988 |
| 24 | Respiratory failure (HP:0002878) | 3.44570622 |
| 25 | Optic disc pallor (HP:0000543) | 3.41293021 |
| 26 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.41254543 |
| 27 | Cerebral edema (HP:0002181) | 3.35572617 |
| 28 | Increased serum lactate (HP:0002151) | 3.30725838 |
| 29 | Abnormality of renal resorption (HP:0011038) | 3.29618154 |
| 30 | Lactic acidosis (HP:0003128) | 3.26303704 |
| 31 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.18275232 |
| 32 | Hypothermia (HP:0002045) | 3.09748051 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 3.09714092 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 3.09714092 |
| 35 | Increased muscle lipid content (HP:0009058) | 3.00406732 |
| 36 | Pancreatic cysts (HP:0001737) | 2.98659616 |
| 37 | True hermaphroditism (HP:0010459) | 2.91666930 |
| 38 | Abnormal number of erythroid precursors (HP:0012131) | 2.82024893 |
| 39 | Respiratory difficulties (HP:0002880) | 2.79156239 |
| 40 | Congenital, generalized hypertrichosis (HP:0004540) | 2.57700618 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.52361951 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.49403955 |
| 43 | Generalized aminoaciduria (HP:0002909) | 2.45909367 |
| 44 | Cerebral hypomyelination (HP:0006808) | 2.45131484 |
| 45 | Aplastic anemia (HP:0001915) | 2.39941727 |
| 46 | Nephronophthisis (HP:0000090) | 2.36017520 |
| 47 | Macrocytic anemia (HP:0001972) | 2.34738497 |
| 48 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.32985896 |
| 49 | Retinal dysplasia (HP:0007973) | 2.32950841 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.27397496 |
| 51 | Abnormality of urine glucose concentration (HP:0011016) | 2.26674639 |
| 52 | Glycosuria (HP:0003076) | 2.26674639 |
| 53 | X-linked dominant inheritance (HP:0001423) | 2.26399297 |
| 54 | Hyperglycinemia (HP:0002154) | 2.15010589 |
| 55 | Sclerocornea (HP:0000647) | 2.13697418 |
| 56 | Reticulocytopenia (HP:0001896) | 2.10732419 |
| 57 | Pheochromocytoma (HP:0002666) | 2.09274957 |
| 58 | CNS demyelination (HP:0007305) | 2.08470047 |
| 59 | Hyperphosphaturia (HP:0003109) | 2.08452799 |
| 60 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.07006953 |
| 61 | Microvesicular hepatic steatosis (HP:0001414) | 2.06592791 |
| 62 | Abnormal hair whorl (HP:0010721) | 2.04069866 |
| 63 | Amniotic constriction ring (HP:0009775) | 2.03045426 |
| 64 | Abnormality of placental membranes (HP:0011409) | 2.03045426 |
| 65 | Emotional lability (HP:0000712) | 1.97873420 |
| 66 | Congenital primary aphakia (HP:0007707) | 1.95201536 |
| 67 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94357661 |
| 68 | Gait imbalance (HP:0002141) | 1.93575724 |
| 69 | Patchy hypopigmentation of hair (HP:0011365) | 1.93289199 |
| 70 | Renal tubular dysfunction (HP:0000124) | 1.91820735 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.91731683 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.91731683 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 1.91731683 |
| 74 | Abnormal glycosylation (HP:0012345) | 1.91731683 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 1.89440281 |
| 76 | Hyperalaninemia (HP:0003348) | 1.89440281 |
| 77 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89440281 |
| 78 | Oral leukoplakia (HP:0002745) | 1.88527223 |
| 79 | Recurrent abscess formation (HP:0002722) | 1.88197712 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 1.87632223 |
| 81 | Abnormality of the labia minora (HP:0012880) | 1.86854741 |
| 82 | Type II lissencephaly (HP:0007260) | 1.84964726 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 1.84603557 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84603557 |
| 85 | Esophageal atresia (HP:0002032) | 1.84148822 |
| 86 | Male pseudohermaphroditism (HP:0000037) | 1.84022782 |
| 87 | Abnormality of the renal medulla (HP:0100957) | 1.83516120 |
| 88 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.82612050 |
| 89 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.82612050 |
| 90 | Methylmalonic acidemia (HP:0002912) | 1.82566360 |
| 91 | Pallor (HP:0000980) | 1.82141224 |
| 92 | Cerebral hemorrhage (HP:0001342) | 1.80997348 |
| 93 | Limb dystonia (HP:0002451) | 1.80297655 |
| 94 | Methylmalonic aciduria (HP:0012120) | 1.79943926 |
| 95 | Myokymia (HP:0002411) | 1.76615054 |
| 96 | Congenital stationary night blindness (HP:0007642) | 1.75725780 |
| 97 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.75259153 |
| 98 | Hypoplasia of the fovea (HP:0007750) | 1.75259153 |
| 99 | Abnormality of vitamin B metabolism (HP:0004340) | 1.75131158 |
| 100 | Sensory axonal neuropathy (HP:0003390) | 1.74793294 |
| 101 | Degeneration of anterior horn cells (HP:0002398) | 1.74373767 |
| 102 | Abnormality of the anterior horn cell (HP:0006802) | 1.74373767 |
| 103 | Hepatosplenomegaly (HP:0001433) | 1.71871988 |
| 104 | Vaginal atresia (HP:0000148) | 1.71827524 |
| 105 | Abnormality of macrophages (HP:0004311) | 1.71740588 |
| 106 | Septo-optic dysplasia (HP:0100842) | 1.71699861 |
| 107 | Autoamputation (HP:0001218) | 1.70992350 |
| 108 | Abnormality of the axillary hair (HP:0100134) | 1.70789210 |
| 109 | Abnormality of secondary sexual hair (HP:0009888) | 1.70789210 |
| 110 | Genital tract atresia (HP:0001827) | 1.70786339 |
| 111 | Abnormal urine phosphate concentration (HP:0012599) | 1.70766047 |
| 112 | Blindness (HP:0000618) | 1.69872806 |
| 113 | Colon cancer (HP:0003003) | 1.69322396 |
| 114 | Abnormal pupillary function (HP:0007686) | 1.69129168 |
| 115 | Abnormality of serum amino acid levels (HP:0003112) | 1.68614680 |
| 116 | Stenosis of the external auditory canal (HP:0000402) | 1.68131452 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.68047120 |
| 118 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67788918 |
| 119 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.64780795 |
| 120 | Lethargy (HP:0001254) | 1.64412259 |
| 121 | CNS hypomyelination (HP:0003429) | 1.64185464 |
| 122 | Optic nerve hypoplasia (HP:0000609) | 1.64029086 |
| 123 | Chronic hepatic failure (HP:0100626) | 1.63596669 |
| 124 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.63005489 |
| 125 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.62975759 |
| 126 | Gastrointestinal atresia (HP:0002589) | 1.61542209 |
| 127 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.60369518 |
| 128 | Recurrent bacterial skin infections (HP:0005406) | 1.60126830 |
| 129 | Renal cortical cysts (HP:0000803) | 1.59484228 |
| 130 | Postnatal microcephaly (HP:0005484) | 1.59082430 |
| 131 | Pancreatic fibrosis (HP:0100732) | 1.58562600 |
| 132 | Increased IgM level (HP:0003496) | 1.58384905 |
| 133 | Poor head control (HP:0002421) | 1.58304691 |
| 134 | Poor suck (HP:0002033) | 1.58198175 |
| 135 | White forelock (HP:0002211) | 1.57914219 |
| 136 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.56767739 |
| 137 | Hypomagnesemia (HP:0002917) | 1.54992961 |
| 138 | Metaphyseal dysplasia (HP:0100255) | 1.53953246 |
| 139 | Spastic paraparesis (HP:0002313) | 1.53914528 |
| 140 | Hypokinesia (HP:0002375) | 1.53813309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK2 | 3.70540360 |
| 2 | VRK2 | 3.52518990 |
| 3 | PBK | 3.39760833 |
| 4 | STK16 | 3.37806303 |
| 5 | MAP4K2 | 3.09549006 |
| 6 | NME2 | 2.88144820 |
| 7 | MAP2K6 | 2.79044554 |
| 8 | MAP3K12 | 2.69723514 |
| 9 | ARAF | 2.60243107 |
| 10 | STK39 | 2.52083935 |
| 11 | MST4 | 2.47219237 |
| 12 | CDK19 | 2.43653820 |
| 13 | BUB1 | 2.42126808 |
| 14 | OXSR1 | 2.39056365 |
| 15 | NME1 | 2.37992544 |
| 16 | BCKDK | 2.19579413 |
| 17 | CASK | 2.17435047 |
| 18 | EIF2AK1 | 2.12661122 |
| 19 | PIM2 | 1.93541257 |
| 20 | BMPR1B | 1.92006286 |
| 21 | EIF2AK3 | 1.90014642 |
| 22 | VRK1 | 1.86712326 |
| 23 | MAPKAPK5 | 1.86027558 |
| 24 | BCR | 1.84983367 |
| 25 | TNIK | 1.80681906 |
| 26 | NUAK1 | 1.80092562 |
| 27 | NEK1 | 1.69679565 |
| 28 | FRK | 1.64597420 |
| 29 | MYLK | 1.58448373 |
| 30 | LIMK1 | 1.55462748 |
| 31 | PINK1 | 1.51545466 |
| 32 | BMPR2 | 1.48802261 |
| 33 | GRK7 | 1.48251532 |
| 34 | MUSK | 1.47389696 |
| 35 | TRIM28 | 1.46797868 |
| 36 | ADRBK2 | 1.44436746 |
| 37 | MAP3K4 | 1.43748488 |
| 38 | MAP3K5 | 1.36969193 |
| 39 | BRAF | 1.34078625 |
| 40 | TESK2 | 1.29919345 |
| 41 | WNK4 | 1.20380475 |
| 42 | PDK2 | 1.17679901 |
| 43 | GRK5 | 1.16734570 |
| 44 | CSNK1G3 | 1.14013127 |
| 45 | DYRK2 | 1.06243346 |
| 46 | RIPK4 | 1.05790020 |
| 47 | TXK | 1.04517872 |
| 48 | MAP2K7 | 1.02303376 |
| 49 | KDR | 1.01841239 |
| 50 | PLK3 | 0.99908053 |
| 51 | IRAK4 | 0.98831727 |
| 52 | ABL2 | 0.98699496 |
| 53 | BLK | 0.93294016 |
| 54 | WEE1 | 0.89747664 |
| 55 | PNCK | 0.89729898 |
| 56 | SRPK1 | 0.87572001 |
| 57 | PLK4 | 0.87446387 |
| 58 | INSRR | 0.87313725 |
| 59 | PHKG2 | 0.86163670 |
| 60 | PHKG1 | 0.86163670 |
| 61 | CAMK2B | 0.84070843 |
| 62 | ERBB3 | 0.83990839 |
| 63 | PLK2 | 0.81415921 |
| 64 | PRKCG | 0.81104835 |
| 65 | TLK1 | 0.78925506 |
| 66 | MARK1 | 0.78439982 |
| 67 | MKNK1 | 0.77440580 |
| 68 | TAOK3 | 0.75913063 |
| 69 | CAMK2D | 0.74026787 |
| 70 | TEC | 0.73082342 |
| 71 | RPS6KA5 | 0.72031566 |
| 72 | FGR | 0.71342819 |
| 73 | PKN1 | 0.69339539 |
| 74 | TAF1 | 0.68979337 |
| 75 | EIF2AK2 | 0.68031702 |
| 76 | TSSK6 | 0.66625230 |
| 77 | MAP3K14 | 0.65902857 |
| 78 | CDC7 | 0.65629179 |
| 79 | DYRK3 | 0.65169125 |
| 80 | MINK1 | 0.65047879 |
| 81 | ACVR1B | 0.64558190 |
| 82 | CDK8 | 0.63942337 |
| 83 | ZAK | 0.63857278 |
| 84 | YES1 | 0.63443567 |
| 85 | IRAK3 | 0.61087090 |
| 86 | CSNK1G1 | 0.61077092 |
| 87 | PLK1 | 0.59801158 |
| 88 | LYN | 0.59726123 |
| 89 | PRKCE | 0.59436868 |
| 90 | MAPK13 | 0.59000783 |
| 91 | CAMK2A | 0.58259378 |
| 92 | FES | 0.58034162 |
| 93 | CAMK2G | 0.57861249 |
| 94 | PAK3 | 0.57219920 |
| 95 | IKBKB | 0.56947656 |
| 96 | NEK6 | 0.56497383 |
| 97 | GRK1 | 0.56176567 |
| 98 | EPHB2 | 0.53898941 |
| 99 | SYK | 0.53277459 |
| 100 | TESK1 | 0.53207003 |
| 101 | CSNK1G2 | 0.52292081 |
| 102 | CSNK1A1L | 0.50093451 |
| 103 | WNK3 | 0.49786338 |
| 104 | ROCK2 | 0.49675751 |
| 105 | SIK3 | 0.49621258 |
| 106 | AURKA | 0.49607488 |
| 107 | MAPKAPK3 | 0.49420052 |
| 108 | KIT | 0.48583001 |
| 109 | ADRBK1 | 0.47442452 |
| 110 | CDK14 | 0.46914600 |
| 111 | BRSK2 | 0.46601083 |
| 112 | UHMK1 | 0.46216302 |
| 113 | MAPK15 | 0.45296152 |
| 114 | DAPK3 | 0.44555417 |
| 115 | CSNK1A1 | 0.44405304 |
| 116 | PAK1 | 0.43733856 |
| 117 | OBSCN | 0.43298013 |
| 118 | CSNK2A1 | 0.43034474 |
| 119 | AURKB | 0.42605295 |
| 120 | SIK2 | 0.42375196 |
| 121 | MOS | 0.41507234 |
| 122 | TTK | 0.41260430 |
| 123 | LCK | 0.38343313 |
| 124 | CCNB1 | 0.38265457 |
| 125 | PRPF4B | 0.37937653 |
| 126 | DAPK1 | 0.37382695 |
| 127 | PRKCD | 0.36011156 |
| 128 | CDK11A | 0.35255917 |
| 129 | CDK18 | 0.35051751 |
| 130 | PRKCI | 0.34518690 |
| 131 | PRKCQ | 0.34063275 |
| 132 | CSNK2A2 | 0.34020035 |
| 133 | CLK1 | 0.33191279 |
| 134 | EPHA4 | 0.32847333 |
| 135 | PRKACA | 0.32389854 |
| 136 | TIE1 | 0.32379438 |
| 137 | ILK | 0.31930483 |
| 138 | CDK15 | 0.31596627 |
| 139 | MKNK2 | 0.30702148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.55673600 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.61726831 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.53355350 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.94460218 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.48970028 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.47110169 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 3.23393632 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.86912185 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.83218977 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.35752021 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.26262213 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92055382 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.74319467 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65972150 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.62023882 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58532300 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.53814062 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48342009 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.43999488 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41307563 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35109687 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.32108295 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31257850 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17116658 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16227203 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14195562 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.12686331 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11763890 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09860169 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08738704 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.06117141 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00713526 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.00191633 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98204641 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 0.97582104 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93503109 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92844595 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 0.92457170 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92391296 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92198427 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 0.92064029 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90979383 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89131366 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88092827 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86361295 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85034132 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.85033793 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.84839434 |
| 49 | Mismatch repair_Homo sapiens_hsa03430 | 0.84138257 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84108331 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83954971 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80934756 |
| 53 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78878060 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77560540 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77336534 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76944568 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76400978 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72766625 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.72535965 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72505340 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72493664 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70423245 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68402176 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67922609 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67429012 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65232292 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64950123 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63275982 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61292430 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 0.61139584 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60964243 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60702492 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59318765 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58040309 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57812151 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56730694 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56288491 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54409024 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52928243 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52833670 |
| 81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51552297 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.51114862 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50494798 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49354130 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48608002 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47093722 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44932479 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.44775814 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.43340258 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41724198 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41669342 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41668862 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40822051 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39725362 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.39624084 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38921114 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38814507 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38251474 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37836634 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37129466 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37105789 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.36862879 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36809704 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.35523823 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34857647 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34362001 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33060610 |
| 108 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33042572 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32826858 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29470147 |
| 111 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29370607 |
| 112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29303866 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.29167739 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.29049671 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28735359 |
| 116 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28384380 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.26818951 |
| 118 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.26384889 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.26248076 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.25541087 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.24467190 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23486859 |
| 123 | RNA transport_Homo sapiens_hsa03013 | 0.23473598 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.23010782 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.22128238 |
| 126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.21527518 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.20831985 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.20537893 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20308864 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.20292105 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18681490 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17198423 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16906346 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.16904999 |
| 135 | Tuberculosis_Homo sapiens_hsa05152 | 0.16668442 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.15789113 |

